[1] A. Jemal, R. Siegel, J. Q. Xu, and E. Ward, “Cancer statistics,” CA: A Cancer Journal for Clinicians, 2010, 60(5): 277-300.

[2] L. M. Brown, S. S. Devesa, and W. H. Chow, “Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age,” Journal of the National Cancer Institute, 2008, 100(16): 1184-1187.

[3] S. S. Devesa, W. J. Blot, and J. F. Fraumeni, “Changing patterns in the incidence of esophageal and gastric carcinoma in the United States,” Cancer, 1998, 83(10): 2049-2053.

[4] R. Krishnamoorthi, S. Singh, K. Ragunathan, D. A. Katzka, K. K. Wang, and P. G. Iyer, “Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy,” Gastrointestinal Endoscopy, 2016, 83(6): 1090-1106.

[5] T. Oyama, A. Tomori, K. Hotta, S. Morita, K. Kominato, M. Tanaka, et al., “Endoscopic submucosal dissection of early esophageal cancer,” Clinical Gastroenterology and Hepatology, 2005, 3(7): S67-S70.

[6] M. Fujishiro, N. Yahagi, N. Kakushima, S. Kodashima, Y. Muraki, S. Ono, et al., “Endoscopic submucosal dissection of esophageal squamous cell neoplasms,” Clinical Gastroenterology and Hepatology, 2006, 4(6): 688-694.

[7] T. Ohki, M. Yamato, M. Ota, R. Takagi, D. Murakami, M. Kondo, et al., “Prevention of esophageal stricture after endoscopic submucosal dissection using tissue-engineered cell sheets,” Gastroenterology, 2012, 143(3): 582-588.

[8] T. Mizumoto, T. Hiyama, S. Ok, N. Yorita, K. Kuroki, M. Kurihara, et al., “Curative criteria after endoscopic resection for superficial esophageal squamous cell carcinomas,” Digestive Diseases and Sciences, 2018, 63(6): 1605-1612.

[9] C. Fleichmann and H. Messmann, “Endoscopic treatment of early esophageal squamous neoplasia,” Minerva Chirurgica, 2018, 73(4): 378-384.

[10] L. Sreedharan, G. C. Mayne, D. I. Watson, T. Bright, R. V. Lord, A. Ansar, et al., “MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett′s esophagus,” World Journal of Gastroenterology, 2017, 23(30): 5508- 5518.

[11] S. N. Choudhury, B. Konwar, S. Kaur, R. Doley, and B. Mondal, “Study on snake venom protein-antibody interaction by surface plasmon resonance spectroscopy,” Photonic Sensors, 2018, 8(3): 193-202.

[12] C. Xiao, Z. B. Chen, M. Z. Qing, D. X. Zhang, and L. Fan, “Composite sinusoidal nanograting with long-range SERS effect for label-free TNT detection,” Photonic Sensors, 2018, 8(3): 1-11.

[13] S. S. Cui, S. Zhang, and S. H. Yue, “Raman spectroscopy and imaging for cancer diagnosis,” Journal of Healthcare Engineering, 2018: 8619342-1-8619342-11.

[14] T. D. Wang, G. Triadafilopoulos, J. M. Crawford, L. R. Dixon, T. Bhandari, P. Sahbaie, et al., “Detection of endogenous biomolecules in Barrett’s esophagus by Fourier transform infrared spectroscopy,” Proceedings of the National Academy of Sciences, 2007, 104(40): 15864-15869.

[15] M. G. Shim, W. K. S L. Michel, N. E. Marcon, and B. C. Wilson, “In vivo near-infrared Raman spectroscopy: demonstration of feasibility during clinical gastrointestinal endoscopy,” Photochemistry and Photobiology, 2000, 72(1): 146-150.

[16] Z. W. Huang, S. K. Teh, W. Zheng, J. H. Mo, K. Lin, X. Z. Shao, et al., “Integrated Raman spectroscopy and trimodal wide-field imaging techniques for real-time in vivo tissue Raman measurements at endoscopy,” Optics Letters, 2009, 34(6): 758- 760.

[17] G. Shetty, C. Kendall, N. Shepherd, N. Stone, and H. Barr, “Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus,” British Journal of Cancer, 2006, 94: 1460–1464.

[18] M. S. Bergholt, W. Zheng, K. Y. Ho, M.Teh, K. G. Yeoh, J. B. Y. So, et al., “Fiber-optic confocal Raman spectroscopy for real-time in vivo diagnosis of dysplasia in Barrett’s esophagus,” Gastroenterology, 2014, 146(1): 27-32.

[19] Y. G. Hu, A. G. Shen, T. Jiang, Y. Ai, and J. M. Hu, “Classification of normal and malignant human gastric mucosa tissue with confocal Raman microspectroscopy and wavelet analysis,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2008, 69(2): 378-382.